{"id":"W4389338940","doi":"10.1038/s41591-023-02696-8","title":"Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"KRAS; Cetuximab; Medicine; Colorectal cancer; Internal medicine; Oncology; Epidermal growth factor receptor; Adverse effect; Confidence interval; Cancer; EGFR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003210593,0.0003467292,0.001034605,0.0004214143,0.0001279382,0.000008292353,0.0001154688,0.0003193525,0.0002878948],"category_scores_gemma":[0.0004986323,0.0002308729,0.0001305399,0.001452971,0.0002299939,0.00005861401,0.00007966225,0.0009198323,0.00003492731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007522609,"about_ca_system_score_gemma":0.0003135104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008463205,"about_ca_topic_score_gemma":0.001127091,"domain_scores_codex":[0.9978048,0.00006341266,0.0004173206,0.0005253802,0.0006603376,0.0005288106],"domain_scores_gemma":[0.9990399,0.0002922024,0.0001089463,0.0002040771,0.0001584848,0.000196428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5665463,0.006341898,0.02243761,0.0005529553,0.00271974,0.01103949,0.02444681,0.00001616646,0.01335979,0.001024351,0.1508219,0.200693],"study_design_scores_gemma":[0.8219079,0.02124526,0.1163677,0.001523312,0.001027882,0.0001167885,0.00215529,0.0006450587,0.004868258,0.0003117901,0.02922943,0.0006013391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616963,0.009101377,0.000002956325,0.01552662,0.002103347,0.001826106,0.0000894901,0.0001926988,0.009461054],"genre_scores_gemma":[0.9929549,0.001591175,0.00002057108,0.001269386,0.001838763,0.0004796698,0.0002149184,0.00003739919,0.001593186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2553616,"threshold_uncertainty_score":0.9414723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02226460767532055,"score_gpt":0.3907521357749205,"score_spread":0.3684875280995999,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}